Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Blood|June 14, 2014
Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosisTobias Herold, Klaus H Metzeler, Sebastian Vosberg, et al.
Nature Communications|September 28, 2021
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targetsMichela Carlet, Kerstin Völse, Jenny Vergalli, et al.
Leukemia|August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease formsSabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 PatientsPhilipp A Greif, Luise Hartmann, Sebastian Vosberg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2024
Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma - A retrospective multicenter study of the Bavarian university hospitalsAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2013
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative studyZejuan Li, Tobias Herold, Chunjiang He, et al.
Annals of Surgical Oncology|May 14, 2025
Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter StudyAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
The Lancet. Oncology|August 11, 2015
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Vindi Jurinovic, Robert Kridel, et al.
Cell Reports|April 25, 2020
Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular LymphomaDeepak Bararia, Johannes A Hildebrand, Sebastian Stolz, et al.
Leukemia|September 19, 2025
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)Monica Cusan, Karilyn Larkin, Deedra Nicolet, et al.
Pageof 7